Partnerships are an important part of the company’s growth strategy. The company is actively exploring alliances that complement our expertise in new uses for previously approved drugs and new molecular entity development with important scientific, clinical and business capabilities. These alliances may incorporate our intellectual property, product candidates and product development capabilities.
To inquire regarding partnership opportunities with Ampio Pharmaceuticals, please contact:
Ampio Pharmaceuticals, Inc.
5445 DTC Parkway, Suite 925
Greenwood Village, CO 80111 USA
Tel: +1 720-437-6500
Fax: +1 720-437-6501
Learn More About:
Premature Ejaculation (PE)
Premature ejaculation is a distressing male sexual dysfunction that is more common than erectile dysfunction (ED) and has a major impact on the quality of life for men and their sexual partners.
Diabetic Retinopathy
A complication of diabetes mellitus that damages the retina in the eyes and leads to blindness
Diabetic Nephropathy
A progressive complication of diabetes mellitus that leads to end-stage renal disease (ESRD) requiring kidney transplantation or chronic dialysis
| AMPE Stock Quote - delayed | ||
| Last | Change | |
| AMPE | ||
Ampio News
01/31/2012 | Press Release
01/26/2012 | News
Register Now For AMPIO’s January 26, 2012 Outlook Call
01/17/2012 | Press Release
Ampio Pharmaceuticals' Zertane™ Patent Estate Bolstered by Two New European Patents